GO:0045905 positive regulation of translational termination: Protein Synthesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045905 describes any process that activates or increases the frequency, rate or extent of translational termination, the final step of protein synthesis when the ribosome releases the completed polypeptide.
• Translational termination is controlled by stop-codon recognition, release factors, and ribosome recycling, and its positive regulation determines how efficiently proteins are made.
• Nonsense-mediated mRNA decay (NMD) is functionally coupled to termination: premature termination codons trigger NMD and influence transcript fate in human cancers.
• Viruses, including coronaviruses and enteroviruses, manipulate termination and reinitiation to control viral gene expression and host translation.
• Dysregulated translation termination and reinitiation contribute to T cell dysfunction in tumors and to resistance to CD8+ T cell exhaustion.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes that regulate translational termination.
Description
GO:0045905, positive regulation of translational termination, is a biological process term that captures any cellular activity that increases the frequency, rate, or extent of translational termination. Translational termination occurs when a ribosome recognizes a stop codon in an mRNA and releases the nascent polypeptide, a step that is essential for accurate proteome maintenance and for controlling how much protein is produced from each transcript. Because termination is coupled to mRNA quality control and to ribosome recycling, its positive regulation influences both protein output and transcript stability. Researchers study this term to understand how cells tune protein synthesis under stress, how viruses hijack translation, and how cancer and immune cells rewire translation to support proliferation or dysfunction. The QuickGO definition provides the authoritative scope: any process that activates or increases the frequency, rate or extent of translational termination. This article integrates that definition with real PubMed literature to outline the mechanisms, key genes, disease links, and experimental methods relevant to GO:0045905.
positive regulation of translational termination At A Glance
| GO ID | GO:0045905 |
|---|---|
| GO term | positive regulation of translational termination |
| Ontology | biological_process |
| Synonym | activation of translational termination; stimulation of translational termination; up regulation of translational termination; up-regulation of translational termination; upregulation of translational termination |
| Major function | Increases the frequency, rate, or extent of translational termination, the stop-codon-dependent release of the nascent polypeptide from the ribosome |
| Related process | Nonsense-mediated mRNA decay (NMD), which is coupled to premature termination and influences transcript fate |
| Viral relevance | Termination-reinitiation mechanisms are used by RNA viruses, including coronaviruses and enteroviruses, to control viral gene expression |
| Disease relevance | Dysregulated translation termination and reinitiation are linked to cancer, immune dysfunction, and viral pathogenesis |
What Is GO:0045905?
In practical terms, positive regulation of translational termination refers to the set of molecular events that make stop-codon recognition and polypeptide release happen more often, faster, or more completely. It includes factors that promote release factor activity, enhance ribosome recycling after termination, and coordinate termination with mRNA surveillance pathways such as nonsense-mediated mRNA decay. The term is not about a single protein but about a regulatory outcome: increased efficiency or frequency of the termination step in translation.
Why Is positive regulation of translational termination Important in Cell Biology?
Positive regulation of translational termination matters because it determines the efficiency and fidelity of protein synthesis and is tightly linked to mRNA quality control. When termination is accelerated or more frequent, cells can rapidly adjust proteome output, recycle ribosomes, and eliminate aberrant transcripts through NMD. This process is also a point of vulnerability exploited by viruses and a node dysregulated in cancer and T cell dysfunction, making it a relevant target for basic and translational research.
• Controls the final step of protein synthesis, ensuring timely release of completed polypeptides.
• Couples translation termination to nonsense-mediated mRNA decay, affecting transcript stability.
• Influences ribosome recycling and global translation efficiency.
• Is exploited by RNA viruses such as coronaviruses and enteroviruses for gene expression.
• Contributes to cancer biology through NMD-sensitive transcripts and translation reprogramming.
• Is linked to T cell dysfunction and resistance to CD8+ T cell exhaustion in tumors.
• Provides a mechanistic entry point for understanding translational control in stress responses.
• Can be studied with CRISPR models to test causal roles of termination regulators.
• Relevant to antiviral and immunotherapy research.
• Supports development of tools for precise translation profiling such as Ribo-seq.
What Happens During positive regulation of translational termination?
Stop-codon recognition and release factor recruitment
In simple terms: The ribosome reads a stop signal and calls in proteins that cut the finished protein loose.
Translational termination begins when a ribosome encounters a stop codon and release factors are recruited to catalyze hydrolysis of the peptidyl-tRNA bond. Positive regulation of this step increases the frequency or rate of stop-codon recognition and release factor activity, allowing faster polypeptide release. In RNA viruses, termination-reinitiation mechanisms can be positively regulated to produce downstream proteins from the same transcript.
Coupling to nonsense-mediated mRNA decay
In simple terms: If a stop signal appears too early, the cell marks the message for destruction.
Premature termination codons trigger nonsense-mediated mRNA decay, a surveillance pathway that degrades aberrant transcripts. The rules and impact of NMD in human cancers show that termination context determines whether a transcript is degraded or translated. Positive regulation of termination can therefore influence NMD efficiency and the fate of NMD-sensitive mRNAs.
Ribosome recycling and reinitiation
In simple terms: After the protein is released, the ribosome is recycled so it can start again.
Following termination, ribosomes are recycled and can reinitiate translation on downstream open reading frames. Positive regulation of termination supports efficient recycling and reinitiation, which is particularly important for viral transcripts with coupled termination-reinitiation. Enterovirus 3A protein disrupts endoplasmic reticulum homeostasis through interaction with GBF1, illustrating how viral proteins can impact host translation-related pathways.
Regulation by cellular signaling and stress
In simple terms: Cell signals can speed up or slow down the ending of protein production.
Cellular signaling pathways and stress responses modulate translation termination and reinitiation. LARP4-mediated hypertranslation drives T cell dysfunction in tumors, showing that translation regulation is linked to immune cell states. The ubiquitin ligase KLHL6 drives resistance to CD8+ T cell dysfunction, further connecting translation-related processes to immune resistance.
Viral manipulation of termination
In simple terms: Viruses can hijack the stop-and-restart system to make their own proteins.
Coronaviruses and other RNA viruses use termination-reinitiation strategies to control viral gene expression. Enterovirus 3A protein disrupts ER homeostasis through GBF1 interaction, which can affect translation and secretory pathways. These examples show that positive regulation of translational termination is a target of viral adaptation.
Key Genes Involved in GO:0045905 positive regulation of translational termination
The following genes and proteins are experimentally linked to translational termination, its positive regulation, or coupled processes such as NMD and reinitiation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KLHL6 | Ubiquitin ligase involved in CD8+ T cell dysfunction resistance | Links protein degradation and immune resistance to translation-related stress |
| LARP4 | RNA-binding protein that promotes hypertranslation | Drives T cell dysfunction in tumors and connects translation to immune exhaustion |
| GBF1 | Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor | Targeted by enterovirus 3A protein, affecting ER homeostasis and translation-related pathways |
| UPF1 | Core NMD factor | Central to nonsense-mediated mRNA decay coupled to termination |
| UPF2 | NMD factor | Participates in NMD and termination surveillance |
| UPF3 | NMD factor | Involved in NMD complex and termination-coupled decay |
| SMG1 | NMD kinase | Phosphorylates UPF1 in NMD, linking termination to transcript fate |
| SMG5 | NMD factor | Functions in NMD and termination surveillance |
| SMG6 | Endonuclease in NMD | Cleaves NMD targets after termination recognition |
| SMG7 | NMD factor | Participates in NMD complex assembly |
| eRF1 | Eukaryotic release factor 1 | Recognizes stop codons and catalyzes peptide release |
| eRF3 | Eukaryotic release factor 3 | GTPase that stimulates eRF1 activity in termination |
| ABCE1 | Ribosome recycling factor | Promotes ribosome recycling after termination |
| PABPC1 | Poly(A)-binding protein | Influences termination and NMD efficiency |
| RPS3 | Ribosomal protein | Part of the small subunit involved in translation and termination context |
| RPL4 | Ribosomal protein | Large subunit component relevant to translation termination |
| RACK1 | Ribosome-associated scaffold | Modulates translation and termination-related signaling |
How Is positive regulation of translational termination Regulated?
Positive regulation of translational termination is controlled by the availability of release factors, the phosphorylation status of NMD factors such as UPF1, and signaling pathways that respond to stress and immune cues. LARP4-mediated hypertranslation in T cells demonstrates that RNA-binding proteins can drive translation states linked to dysfunction. KLHL6-mediated ubiquitination influences resistance to CD8+ T cell dysfunction, connecting protein turnover to translation-related immune regulation. Viral proteins such as enterovirus 3A can disrupt ER homeostasis and indirectly affect translation.
positive regulation of translational termination and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UPF1 | Cancer and NMD-sensitive transcript regulation | CRISPR knockout in cancer cell lines followed by RNA-seq |
| LARP4 | T cell dysfunction in tumors | Overexpression and knockout in primary T cells |
| KLHL6 | Resistance to CD8+ T cell dysfunction | Knockout and point-mutation models in T cells |
| GBF1 | Enterovirus-induced ER stress | Knockout and tagged knock-in in epithelial cells |
| eRF1 | Translation termination fidelity | Point-mutation knock-in in reporter cell lines |
Cancer and NMD-sensitive transcripts
Nonsense-mediated mRNA decay, which is coupled to translational termination, shapes the expression of many transcripts in human cancers. The rules and impact of NMD in human cancers indicate that termination context can determine whether oncogenic or tumor-suppressive transcripts are degraded. Positive regulation of termination may therefore influence cancer cell proteomes and drug responses.
T cell dysfunction and immunotherapy resistance
LARP4-mediated hypertranslation drives T cell dysfunction in tumors, linking translation regulation to immune exhaustion. KLHL6 drives resistance to CD8+ T cell dysfunction, showing that protein degradation and translation-related pathways contribute to immunotherapy resistance. These findings suggest that targeting translation termination regulators could modulate anti-tumor immunity.
Viral pathogenesis
Coronaviruses and enteroviruses exploit termination-reinitiation and host translation machinery for gene expression. Enterovirus 3A protein disrupts ER homeostasis through GBF1 interaction, affecting cellular pathways tied to translation. Understanding positive regulation of termination may inform antiviral strategies.
Neurodevelopmental and synaptic proteoforms
Alternative translation initiation produces synaptic organizer proteoforms with distinct localization and functions, highlighting how translation control generates protein diversity. Although not directly about termination, these findings show that translation steps are finely regulated in neurons.
From positive regulation of translational termination-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of an NMD factor alter termination efficiency? | CRISPR knockout of UPF1 or SMG genes followed by Ribo-seq |
| Does LARP4 overexpression drive T cell dysfunction? | Overexpression in primary T cells and tumor models |
| Does KLHL6 mutation affect CD8+ T cell resistance? | Point-mutation knock-in in T cells |
| How does enterovirus 3A affect GBF1 function? | Tagged knock-in of GBF1 and viral infection |
| Can termination-reinitiation be measured quantitatively? | Reporter knock-in with dual luciferase |
| Do synaptic proteoforms depend on alternative initiation? | Knock-in of tagged isoforms in neurons |
How to Study the positive regulation of translational termination Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and termination efficiency | Quantify positive regulation of termination |
| RNA-seq | Transcript abundance and NMD sensitivity | Identify NMD targets in cancer |
| Dual-luciferase reporter | Termination-reinitiation efficiency | Test viral and cellular regulators |
| Mass spectrometry | Protein output and proteoform diversity | Measure translation products |
| CRISPR knockout | Loss-of-function effects | Test causal roles of termination regulators |
| CRISPR knock-in | Tagged or mutant protein expression | Study localization and function |
| Immunofluorescence | Protein localization | Assess ER and translation compartment changes |
| Flow cytometry | Immune cell phenotypes | Evaluate T cell dysfunction |
Ribosome profiling (Ribo-seq)
Ribo-seq measures ribosome occupancy across transcripts and can reveal changes in termination efficiency and reinitiation. It is used to quantify how positive regulation of termination alters translation output.
RNA-seq and NMD target analysis
RNA-seq combined with NMD inhibition identifies transcripts sensitive to termination-coupled decay. This approach helps determine how positive regulation of termination affects transcript stability.
Proteomics and reporter assays
Mass spectrometry and dual-luciferase reporters quantify protein output and termination-reinitiation efficiency. These methods are used to test whether candidate regulators increase termination frequency.
Imaging and localization studies
Fluorescence imaging of tagged proteins such as GBF1 reveals how viral proteins disrupt ER homeostasis and translation-related compartments. Localization studies of synaptic proteoforms show distinct functions of translation variants.
How CRISPR Can Be Used to Study GO:0045905 positive regulation of translational termination
Knockout
CRISPR knockout of genes such as UPF1, SMG1, or LARP4 can test whether they are required for positive regulation of translational termination and downstream phenotypes. Knockout models are useful for measuring changes in NMD and translation efficiency.
Point Mutation
Point-mutation knock-in of release factor or NMD factor residues can dissect catalytic and regulatory domains. Such models help determine which residues are essential for termination enhancement.
Knock-in
Tagged knock-in of GBF1 or ribosomal proteins allows localization and interaction studies in the context of viral infection. Knock-in reporters can quantify termination-reinitiation in live cells.
Overexpression
Overexpression of LARP4 or KLHL6 can model T cell dysfunction and resistance phenotypes observed in tumors. Overexpression systems are also used to test whether a candidate gene is sufficient to increase termination.
How EDITGENE Supports positive regulation of translational termination Research
Researchers studying positive regulation of translational termination-related genes often need to determine whether a candidate gene is causally involved in termination efficiency, NMD, or immune cell phenotypes. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses with publication-ready rigor.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of translational termination research.
Frequently Asked Questions About positive regulation of translational termination
What is positive regulation of translational termination (GO:0045905)?
It is any process that activates or increases the frequency, rate, or extent of translational termination, the stop-codon-dependent release of the polypeptide from the ribosome.
What genes are involved in positive regulation of translational termination?
Genes include release factors such as eRF1 and eRF3, recycling factors such as ABCE1, and NMD factors such as UPF1, SMG1, and SMG6.
How is translational termination linked to nonsense-mediated mRNA decay?
Premature termination codons trigger NMD, and the rules of NMD in human cancers show that termination context determines transcript fate.
Why is positive regulation of translational termination important in cancer?
NMD-sensitive transcripts and translation reprogramming affect cancer cell proteomes and drug responses.
How do viruses manipulate translational termination?
RNA viruses use termination-reinitiation strategies, and enterovirus 3A disrupts ER homeostasis through GBF1 interaction.
What methods are used to study translational termination?
Ribo-seq, RNA-seq, dual-luciferase reporters, proteomics, and imaging are commonly used.
Can CRISPR be used to study positive regulation of translational termination?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models can test causal roles of termination regulators.
What is the role of LARP4 in T cell dysfunction?
LARP4-mediated hypertranslation drives T cell dysfunction in tumors.
How does KLHL6 relate to CD8+ T cell dysfunction?
KLHL6 is a ubiquitin ligase that drives resistance to CD8+ T cell dysfunction.
What is termination-reinitiation in RNA viruses?
It is a mechanism where ribosomes terminate at a stop codon and reinitiate downstream, used by viruses to control gene expression.
Conclusion
GO:0045905, positive regulation of translational termination, is a critical biological process that controls the final step of protein synthesis and is coupled to mRNA quality control. Its dysregulation is linked to cancer, immune dysfunction, and viral pathogenesis, making it a rich area for mechanistic and translational research. CRISPR-based models and advanced profiling methods provide powerful tools to dissect how this process is regulated and to identify therapeutic targets.
References
- 1. Cheng H et al.. 2026. The ubiquitin ligase KLHL6 drives resistance to CD8(+) T cell dysfunction.. Nature 651(8105):451-461 PMID: 41535474
- 2. Lindeboom RG et al.. 2016. The rules and impact of nonsense-mediated mRNA decay in human cancers.. Nat Genet 48(10):1112-8 PMID: 27618451
- 3. Gollnick P et al.. 2002. Transcription attenuation.. Biochim Biophys Acta 1577(2):240-50 PMID: 12213655
- 4. Liu Y et al.. 2025. LARP4-mediated hypertranslation drives T cell dysfunction in tumors.. Nat Immunol 26(9):1488-1500 PMID: 40696044
- 5. Taguchi F. 2011. [Coronaviruses].. Uirusu 61(2):205-10 PMID: 22916567
- 6. Lee PJ et al.. 2024. Alternative translation initiation produces synaptic organizer proteoforms with distinct localization and functions.. Mol Cell 84(20):3967-3978.e8 PMID: 39317199
- 7. Powell ML. 2010. Translational termination-reinitiation in RNA viruses.. Biochem Soc Trans 38(6):1558-64 PMID: 21118126
- 8. Hirano J et al.. 2024. Enterovirus 3A protein disrupts endoplasmic reticulum homeostasis through interaction with GBF1.. J Virol 98(7):e0081324 PMID: 38904364
